Drugs / HMPL-295S1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04908046 | May 2021 → Jan 2024 | cancer | Hutchmed | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HMPL-295S1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04908046 ↗ |
| Route | Oral | “patients will receive oral HMPL-295S1 QD continuously” NCT04908046 ↗ |